We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+19.18%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$14.1B
AUM Growth
+$3.8B
Cap. Flow
+$2.09B
Cap. Flow %
14.81%
Top 10 Hldgs %
19.63%
Holding
2,124
New
675
Increased
443
Reduced
410
Closed
576

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$131M
2
MSFT icon
Microsoft
MSFT
+$129M
3
V icon
Visa
V
+$119M
4
BKNG icon
Booking.com
BKNG
+$86M
5
HUM icon
Humana
HUM
+$82.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 15.37%
3 Consumer Discretionary 10.44%
4 Industrials 8.59%
5 Financials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUPV
1426
Grupo Supervielle
SUPV
$753M
$14K ﹤0.01%
+2,300
New +$20.5K
TSLX icon
1427
Sixth Street Specialty
TSLX
$1.81B
$14K ﹤0.01%
+700
New +$13.9K
XNCR icon
1428
Xencor
XNCR
$1.55B
$14K ﹤0.01%
+439
New +$14.6K
TPC
1429
Tutor Perini Cor
TPC
$5.21B
$14K ﹤0.01%
800
+796
+19,900% +$13.9K
AGR
1430
DELISTED
Avangrid, Inc.
AGR
$14K ﹤0.01%
284
-13,747
-98% -$678K
ARGO
1431
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$14K ﹤0.01%
+200
New +$13.6K
GTT
1432
DELISTED
GTT Communications, Inc.
GTT
$14K ﹤0.01%
400
-83,257
-100% -$2.44M
BAK icon
1433
Braskem
BAK
$913M
$13K ﹤0.01%
500
-6,785
-93% -$188K
CERS icon
1434
Cerus
CERS
$474M
$13K ﹤0.01%
+2,145
New +$13K
GYRE icon
1435
Gyre Therapeutics
GYRE
$744M
$13K ﹤0.01%
217
+55
+34% +$3.53K
HAPN
1436
Happen Inc
HAPN
$2.24B
$13K ﹤0.01%
+820
New +$12.7K
PGEN icon
1437
Precigen
PGEN
$2.59B
$13K ﹤0.01%
2,448
-3,969
-62% -$27.5K
QUAD icon
1438
Quad
QUAD
$525M
$13K ﹤0.01%
+1,100
New +$14.8K
PRKS icon
1439
United Parks & Resorts
PRKS
$2.12B
$13K ﹤0.01%
500
-961
-66% -$24.5K
CCLP
1440
DELISTED
CSI Compressco LP
CCLP
$13K ﹤0.01%
+4,625
New +$12.9K
FBC
1441
DELISTED
Flagstar Bancorp, Inc. New
FBC
$13K ﹤0.01%
+400
New +$12.5K
FBNC icon
1442
First Bancorp
FBNC
$2.68B
$12K ﹤0.01%
+347
New +$12.7K
MATV icon
1443
Mativ Holdings
MATV
$711M
$12K ﹤0.01%
+300
New +$10.2K
MBI icon
1444
MBIA
MBI
$260M
$12K ﹤0.01%
+1,283
New +$12.6K
OPI
1445
DELISTED
Office Properties Income Trust
OPI
$12K ﹤0.01%
+429
New +$13K
MCRN
1446
DELISTED
Milacron Holdings Corp.
MCRN
$12K ﹤0.01%
+1,023
New +$13.5K
NRE
1447
DELISTED
NorthStar Realty Europe Corp.
NRE
$12K ﹤0.01%
+700
New +$11.9K
BBDC icon
1448
Barings BDC
BBDC
$965M
$11K ﹤0.01%
+1,133
New +$11.1K
MPX
1449
DELISTED
Marine Products Corp
MPX
$11K ﹤0.01%
+816
New +$12.1K
UVV icon
1450
Universal Corp
UVV
$1.27B
$11K ﹤0.01%
+197
New +$11.3K

Similar funds

Marshall Wace North America's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace North America held 2,124 positions worth $14.1B, up 37% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America deployed $2.09B of net new capital in Q1 2019, opening 675 new positions and adding to 443 existing holdings. Its largest new stake was bluebird bio: 36,744 shares worth $74.9M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Comcast, an estimated $131M trimmed.

  • Marshall Wace North America's largest Q1 2019 buy was bluebird bio: 36,744 shares worth $74.9M.
  • Marshall Wace North America added most to Fidelity National Information Services in Q1 2019, an estimated $188M increase.
  • Marshall Wace North America's biggest Q1 2019 reduction was Comcast, cutting an estimated $131M.
  • Marshall Wace North America fully exited Cboe Global Markets in Q1 2019, selling an estimated $67.7M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $14.1B portfolio in Q1 2019.
  • Marshall Wace North America opened 675 new positions and closed 576 in Q1 2019.
  • Marshall Wace North America's portfolio value rose 37% quarter-over-quarter to $14.1B.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.